Frontlight ResearchEarly access
Ovarian cancer trials in Puerto Rico
13 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleTargeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Where
- Bayamón, Manati, San Juan
- People
- 2,900 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05564377 - Phase 3Taking peopleTesting Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Where
- Bayamón, Manati, San Juan
- Age
- 18 years and over
- People
- 880 worldwide
- Run by
- NRG Oncology
See details and how to joinNCT06580314 - Phase 3Taking peopleA Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
- Where
- San Juan
- Age
- 18 years and over
- People
- 420 worldwide
- Run by
- K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
See details and how to joinNCT07546500 - Phase 3Taking peopleEvaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Where
- Bayamón, Manati, San Juan
- Age
- 18 years to 60 years
- People
- 3,960 worldwide
- Run by
- NRG Oncology
See details and how to joinNCT05879926 - Phase 2Taking peopleA Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Where
- San Juan
- Age
- 18 years and over
- People
- 310 worldwide
- Run by
- K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
See details and how to joinNCT05128825 · EU 2022-502983-19-00 - Phase 1/2Taking peopleA Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Where
- San Juan
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- Terremoto Biosciences Inc.
See details and how to joinNCT07109726 - Phase 3Enrolling by invitationSafety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study
- Where
- San Juan
- Age
- 18 years to 51 years
- People
- 250 worldwide
- Run by
- Tolmar Inc.
See details and how to joinNCT05645536 - Phase 3CompletedStudy to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Where
- San Juan, Yauco
- Age
- 18 years and over
- People
- 466 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07214779 · EU 2025-522748-42-00 - Phase 1Taking peopleStudy to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
- Where
- Rio Piedras
- Age
- 18 years and over
- People
- 325 worldwide
- Run by
- AbbVie
See details and how to joinNCT06084481 · EU 2023-506227-29-00 - Phase 1/2Taking peopleStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Where
- San Juan
- Age
- 18 years and over
- People
- 534 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06128551 - Phase 2Taking peopleA Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Where
- San Juan
- Age
- 18 years to 99 years
- People
- 160 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07023627 · EU 2025-521513-14-00 - Phase 3Active, not recruitingActive Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- Where
- Caguas, San Juan
- People
- 1,780 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT03067181 - No phaseTaking peopleSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Where
- San Juan
- People
- 50,000 worldwide
- Run by
- Massive Bio, Inc.
See details and how to joinNCT03452774